C4 glomerulopathy: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{C4 glomerulopathy}} | {{C4 glomerulopathy}} | ||
{{CMG}}; {{APM}} {{AE}; {{OO}} | {{CMG}}; {{APM}} {{AE}}; {{OO}} | ||
{{SK}} glomerulonephritis; C4 glomerulonephritis; dense deposit disease | {{SK}} glomerulonephritis; C4 glomerulonephritis; dense deposit disease |
Revision as of 12:11, 15 November 2016
C4 glomerulopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
C4 glomerulopathy On the Web |
American Roentgen Ray Society Images of C4 glomerulopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2] Associate Editor(s)-in-Chief: ; Olufunmilola Olubukola M.D.[3]
Synonyms and keywords: glomerulonephritis; C4 glomerulonephritis; dense deposit disease
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating C4 glomerulopathy from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Studies | Other Diagnostic Studies
Treatment
Surgery | Medical therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies